Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia

Krzysztof Giannopoulos1, Michael Schmitt, Malgorzata Kowal

  • 1Department of Internal Medicine III, University of Ulm, Ulm, Germany. krzysztof.giannopoulos@alumni.uni-ulm.de

Oncology Reports
|August 13, 2008
PubMed

Insights

Immune system dysfunction in B-cell chronic lymphocytic leukemia (B-CLL) is linked to increased T regulatory cells (Treg). Higher Treg frequencies in B-CLL patients correlate with reduced immune responses to tumor and viral antigens, indicating a key immunosuppression mechanism.

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is characterized by immune dysregulation, including immunodeficiency and autoimmunity.
  • The precise role of T regulatory lymphocytes (Treg) in the compromised immune status of B-CLL patients remains incompletely understood.

Purpose of the Study:

  • To investigate the frequency and functional impact of T regulatory lymphocytes (Treg) expressing FOXP3 in B-CLL patients.
  • To assess the correlation between Treg levels and disease progression, prognostic markers, and immune responses against tumor and viral antigens.

Main Methods:

  • Flow cytometry was used to quantify CD4+CD25hi FOXP3+ Treg cells in 80 B-CLL patients and healthy volunteers (HV).
  • Treg frequencies were analyzed in relation to B-CLL disease stages (Binet classification), prognostic markers (ZAP-70, CD38, HLA-G), and serum TNF levels.
  • T-cell immune responses against tumor-associated antigens (survivin, fibromodulin, RHAMM) and influenza matrix protein were evaluated.

Main Results:

  • B-CLL patients exhibited significantly higher frequencies of Treg compared to HV, with levels increasing alongside disease progression (Stage A, B, C).
  • Treg frequency correlated positively with serum TNF levels but showed no correlation with ZAP-70, CD38, or HLA-G.
  • Elevated Treg frequencies were associated with diminished T-cell responses against both viral and tumor-associated antigens.

Conclusions:

  • This study confirms increased Treg frequencies in B-CLL patients, which rise with disease progression.
  • T regulatory lymphocytes play a critical role in mediating immunosuppression within the B-CLL microenvironment.
  • The findings highlight Treg as a significant factor contributing to the impaired immune surveillance observed in B-CLL.